Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
Financial Data
-
31st Dec 18 Source: CRO
- €13.7 billion turnover
-
€2.4 billion
profit - 22,000 employees
-
31st Dec 17 Source: CRO
- €12.4 billion turnover
-
€3.5 billion
profit - 22,000 employees
- 10 more years available »
Ranking
By Turnover
(€13.7 billion)- 13th in Top Companies
- 2nd in Pharma
By Employees
(22,000)- 8th in Top Companies
- 1st in Pharma
-
- 22,000
- €13.7 billion
Employees
- Susan Hynes Vice President}
Latest News
- 6:10am Chambers Ireland warns July stimulus is ‘last chance’ to save the economy
- 6:00am Seabren secures €5.7m from sale of Dublin 12 social housing units
- 6:00am Singaporean developer pays over €3m for Citywest lands
- 6:00am Marlet completes €46m sale of Dublin docklands apartments
- 6:00am Johnny Ronan offered Bewley’s the option to buy Grafton Street building